These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 23212560

  • 1. Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
    Delbe-Bertin L, Aoun B, Tudorache E, Lapillone H, Ulinski T.
    Pediatr Nephrol; 2013 Mar; 28(3):447-51. PubMed ID: 23212560
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome.
    Parmentier C, Delbet JD, Decramer S, Boyer O, Hogan J, Ulinski T.
    Pediatr Nephrol; 2020 Mar; 35(3):455-462. PubMed ID: 31705306
    [Abstract] [Full Text] [Related]

  • 3. Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.
    Fujinaga S, Ozawa K, Sakuraya K, Yamada A, Shimizu T.
    Clin Nephrol; 2016 Jun; 85(6):340-5. PubMed ID: 27125626
    [Abstract] [Full Text] [Related]

  • 4. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 5. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.
    Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.
    Pediatr Nephrol; 2011 Oct 01; 26(10):1823-8. PubMed ID: 21556716
    [Abstract] [Full Text] [Related]

  • 6. Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey.
    Zurowska A, Drozynska-Duklas M, Topaloglu R, Bouts A, Boyer O, Shenoy M, Vivarelli M, ESPN Glomerulonephritis Working Group.
    Pediatr Nephrol; 2023 Sep 01; 38(9):3035-3042. PubMed ID: 37014530
    [Abstract] [Full Text] [Related]

  • 7. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
    Clin Exp Nephrol; 2017 Aug 01; 21(4):671-676. PubMed ID: 27558467
    [Abstract] [Full Text] [Related]

  • 8. Incidence and risk factors of rituximab-associated hypogammaglobulinemia in patients with complicated nephrotic syndrome.
    Inoki Y, Kamei K, Nishi K, Sato M, Ogura M, Ishiguro A.
    Pediatr Nephrol; 2022 May 01; 37(5):1057-1066. PubMed ID: 34606002
    [Abstract] [Full Text] [Related]

  • 9. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
    Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guérin V, Lapillonne H, Deschênes G, Ulinski T.
    Nephrol Dial Transplant; 2012 Mar 01; 27(3):1083-9. PubMed ID: 21810762
    [Abstract] [Full Text] [Related]

  • 10. Idiopathic nephrotic syndrome and rituximab: may we predict circulating B lymphocytes recovery?
    Delbet JD, Leclerc G, Ulinski T.
    Pediatr Nephrol; 2019 Mar 01; 34(3):529-532. PubMed ID: 30542932
    [Abstract] [Full Text] [Related]

  • 11. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
    Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.
    Pediatr Nephrol; 2008 Aug 01; 23(8):1269-79. PubMed ID: 18465150
    [Abstract] [Full Text] [Related]

  • 12. Novel use of rituximab for steroid-dependent nephrotic syndrome in children.
    Kimata T, Hasui M, Kino J, Kitao T, Yamanouchi S, Tsuji S, Kaneko K.
    Am J Nephrol; 2013 Aug 01; 38(6):483-8. PubMed ID: 24296765
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J, Du J, Wang S, Xiao L, Zhao X.
    Zhonghua Er Ke Za Zhi; 2014 Jul 01; 52(7):521-4. PubMed ID: 25224058
    [Abstract] [Full Text] [Related]

  • 14. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
    Levy R, Mahévas M, Galicier L, Boutboul D, Moroch J, Loustau V, Guillaud C, Languille L, Fain O, Bierling P, Khellaf M, Michel M, Oksenhendler E, Godeau B.
    Autoimmun Rev; 2014 Oct 01; 13(10):1055-63. PubMed ID: 25183241
    [Abstract] [Full Text] [Related]

  • 15. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
    Ito S, Kamei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K.
    Pediatr Nephrol; 2013 Feb 01; 28(2):257-64. PubMed ID: 23052656
    [Abstract] [Full Text] [Related]

  • 16. Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome.
    Sellier-Leclerc AL, Belli E, Guérin V, Dorfmüller P, Deschênes G.
    Pediatr Nephrol; 2013 Sep 01; 28(9):1875-9. PubMed ID: 23700173
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
    Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
    Eur J Pediatr; 2013 Apr 01; 172(4):513-8. PubMed ID: 23271494
    [Abstract] [Full Text] [Related]

  • 18. Impact of rituximab on height and weight in children with refractory steroid-dependent nephrotic syndrome.
    Sato M, Ito S, Ogura M, Kamei K.
    Pediatr Nephrol; 2014 Aug 01; 29(8):1373-9. PubMed ID: 24599443
    [Abstract] [Full Text] [Related]

  • 19. [Incidence of hypogammaglobulinaemia in children with steroid-dependent/frequently relapsing nephrotic syndrome treated with rituximab and its association with severe infections].
    Zhi YZ, Cao L, Ying DJ, Dou WJ, Gu R, Zhang JJ.
    Zhonghua Yi Xue Za Zhi; 2024 Feb 06; 104(6):433-439. PubMed ID: 38326055
    [Abstract] [Full Text] [Related]

  • 20. Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.
    Hogan J, Dossier C, Kwon T, Macher MA, Maisin A, Couderc A, Niel O, Baudouin V, Deschênes G.
    Pediatr Nephrol; 2019 Feb 06; 34(2):253-259. PubMed ID: 30109447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.